In this study, microvascular injury was detected in 5 COVID-19 patients which had “deposits of terminal complement components C5b-9 (membrane attack complex), C4d, and mannose binding lectin (MBL)-associated serine protease (MASP)2” in their pulmonary tissue.32 This evidence concerns the gene MASP2 and COVID-19.